ImaBiotech is proud to announce the certification to the ISO 9001: 2015 quality management.
It covers the development, the analysis and the report of Mass Spectrometry Imaging and all the other lab activities focused on quality management system, risk management and performance. With a GLP environment, GCP compliant Laboratories and the ISO certification, ImaBiotech has the capacity to run preclinical and clinical trials while providing the expected quality standard to the regulatory agencies.
By meeting this standard, ImaBiotech has shown commitment and ability to consistently provide services that meet customers’ and authorities’ expectations with a focus on risk-based thinking that help efficiency and implementation of continuous improvement. As a testimony of our commitment we’ve established SOPs and QA/ QC control about data recording and verification with a new data architecture backup and monitoring strategy that will be presented at the ASMS Conference, Atlanta, GA in June.
“We hold ourselves to high standards at ImaBiotech, and continually strive to raise that bar in the quality and accuracy of our services. We are daily working on continuous improvement of our processes. This success could not have been achieved without tight co-operation of all our team” Dr. Jonathan Stauber, CEO.
ISO 9001:2015 requires a company to identify, define, document, implement, monitor and measure, and continually improve the effectiveness of its processes.